MetLife Valuation

MET -- USA Stock  

USD 41.79  1.43  3.31%

MetLife secures last-minute Real Value of $49.315 per share. The latest price of the firm is $41.79. At this time the firm appears to be undervalued. Macroaxis forecasts value of MetLife from analyzing the firm fundamentals such as Profit Margin of 7.54%, Return On Equity of 9.17% and Current Valuation of 109.66B as well as examining its technical indicators and Probability Of Bankruptcy. In general, we recommend to purchase undervalued stocks and to get rid of overvalued stocks since at some point entities prices and their ongoing real values will merge together.

Valuation Drivers Correlation

Click cells to compare fundamentals   View All Correlations
MetLife Valuation Data Drivers
Net Income Per Employee    Enterprise Value    Market Capitalization    

MetLife Market Cap

MetLife is considered to be number one stock in market capitalization category among related companies. Market capitalization of Insurance - Life industry is now estimated at about 91.28 Billion. MetLife totals roughly 40 Billion in market capitalization claiming about 44% of equities under Insurance - Life industry.
Capitalization  Revenue  Valuation  Total debt  Workforce
Horizon     30 Days    Login   to change
MetLife is rated below average in price to earning category among related companies. It is considered to be number one stock in five year return category among related companies reporting about  0.36  of Five Year Return per Price to Earning. The ratio of Price to Earning to Five Year Return for MetLife is roughly  2.77 

Current Market Valuation

MetLife Valuation Boundaries

March 24, 2019
Market Value
Real Value
Target Odds
Odds Odds
MetLife is very steady asset. Calculation of real value of MetLife is based on 2 months time horizon. Increasing MetLife time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.

Valuation Basics

MetLife Enterprise Value Fundamentals

Quick Ratio0.93
Earnings Quarterly Growth-10.80%
Revenue Growth-1.00%
Payout Ratio33.81%
Enterprise Value To Ebitda14.03
Earnings Growth-4.80%
Enterprise Value To Revenue1.62
Please see also Stocks Correlation. Please also try Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.